ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs MXN
18.14692
0.11%
Brent Oil
84.935
0.89%
Bitcoin
61,314.03
-0.80%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. BioAtla Inc (BCAB)

  7. BioAtla Inc (BCAB) Noticias

BCAB

BioAtla (BCAB)

BioAtla Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BCAB
FechaHoraFuenteTítuloSímboloCompañía
14/06/202415:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCABBioAtla Inc
13/06/202416:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCABBioAtla Inc
14/05/202416:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCABBioAtla Inc
15/06/202317:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCABBioAtla Inc
14/06/202316:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCABBioAtla Inc
11/05/202316:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCABBioAtla Inc
27/04/202311:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BCABBioAtla Inc
24/04/202316:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BCABBioAtla Inc
23/03/202316:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BCABBioAtla Inc
23/03/202316:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCABBioAtla Inc
14/02/202315:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCABBioAtla Inc
06/02/202313:51Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:BCABBioAtla Inc
09/01/202316:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BCABBioAtla Inc
06/01/202315:21Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BCABBioAtla Inc
29/12/202215:05PR Newswire (US)Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of DirectorsNASDAQ:BCABBioAtla Inc
07/11/202223:35TipRanksJMP Securities Reaffirms Their Buy Rating on BioAtla (BCAB)NASDAQ:BCABBioAtla Inc
04/11/202205:36TipRanksBioAtla (BCAB) Receives a Buy from H.C. WainwrightNASDAQ:BCABBioAtla Inc
04/11/202204:55TipRanksBioAtla Pops After Encouraging Q3 ResultsNASDAQ:BCABBioAtla Inc
20/09/202216:54Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BCABBioAtla Inc
20/09/202216:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:BCABBioAtla Inc
14/09/202223:35TipRanksBioAtla (BCAB) Receives a Buy from JMP SecuritiesNASDAQ:BCABBioAtla Inc
12/09/202209:08PR Newswire (US)Himalaya Therapeutics Announces Interim Phase 2 Results for Mecbotamab vedotin (HTBA3011)NASDAQ:BCABBioAtla Inc
10/08/202205:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for BioAtla (BCAB)NASDAQ:BCABBioAtla Inc
17/05/202216:28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BCABBioAtla Inc
15/05/202208:20TipRanksBioAtla (BCAB) Receives a Buy from J.P. MorganNASDAQ:BCABBioAtla Inc
13/03/202207:35TipRanksJ.P. Morgan Thinks BioAtla’s Stock is Going to RecoverNASDAQ:BCABBioAtla Inc
01/03/202205:00PR Newswire (US)BIOATLA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTSNASDAQ:BCABBioAtla Inc
04/02/202208:17Edgar (US Regulatory)Schedule 13gNASDAQ:BCABBioAtla Inc
02/02/202216:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCABBioAtla Inc
01/02/202209:19ValueWalkThese Are The Ten Worst Performing Small Cap Stocks In January 2022NASDAQ:BCABBioAtla Inc
 Showing the most relevant articles for your search:NASDAQ:BCAB

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
CCOM
OILBRENT
Brent Oil
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
USOTC
ADDYY
Adidas (QX)
FX
USDMXN
US Dollar vs MXN
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
COIN
SOLUSD
Solana
FX
EURUSD
Euro vs US Dollar
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados